Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-10 Option Award | 2025-06-12 5:51 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Ball Titus B. Principal Accounting Officer | 29,601 | $0 | 0 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-12 5:49 pm | N/A 2035-06-09 | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 135,122 | $0 | 372,164 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-12 5:45 pm | N/A 2035-06-09 | BeOne Medicines Ltd. | ONC | Rosenberg Aaron Chief Financial Officer | 183,547 | $0 | 350,675 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-12 5:44 pm | N/A 2035-06-09 | BeOne Medicines Ltd. | ONC | Wang Lai Global Head of R&D | 248,924 | $0 | 1,952,834 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-12 5:42 pm | N/A 2035-06-09 | BeOne Medicines Ltd. | ONC | Wu Xiaobin President and COO | 355,615 | $0 | 1,522,906 (Direct) | View |
| 2025-06-10 Exercise | 2025-06-12 5:39 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Wang Xiaodong Chair, Scientific Advisory Brd | 41,760 | $6.5 | 5,164,016 (Direct) | View |
| 2025-06-10 Exercise | 2025-06-12 5:39 pm | N/A 2025-07-19 | BeOne Medicines Ltd. | ONC | Wang Xiaodong Chair, Scientific Advisory Brd | 542,880 | $0 | 5,164,016 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-12 5:39 pm | N/A 2035-06-09 | BeOne Medicines Ltd. | ONC | Wang Xiaodong Chair, Scientific Advisory Brd | 284,492 | $0 | 5,164,016 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-12 5:38 pm | N/A 2035-06-09 | BeOne Medicines Ltd. | ONC | OYLER JOHN Chief Executive Officer | 533,429 | $0 | 54,685,531 (Direct) | View |
| 2025-06-10 Other | 2025-06-12 4:19 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Yi Qingqing Director | 29,614 | $0 | 56,940 (Direct) | View |
| 2025-05-21 Option Award | 2025-05-23 4:05 pm | N/A 2035-05-20 | BeiGene Ltd. | BGNE | Yi Qingqing Director | 33,735 | $0 | 79,690 (Direct) | View |
| 2025-05-21 Option Award | 2025-05-22 7:47 pm | N/A 2035-05-20 | BeiGene Ltd. | BGNE | Sharp Shalini Director | 33,735 | $0 | 41,886 (Direct) | View |
| 2025-05-21 Option Award | 2025-05-22 7:46 pm | N/A 2035-05-20 | BeiGene Ltd. | BGNE | BRANDICOURT OLIVIER Director | 33,735 | $0 | 50,076 (Direct) | View |
| 2025-05-21 Option Award | 2025-05-22 7:44 pm | N/A 2035-05-20 | BeiGene Ltd. | BGNE | Riva Alessandro Director | 33,735 | $0 | 79,690 (Direct) | View |
| 2025-05-21 Option Award | 2025-05-22 7:44 pm | N/A 2035-05-20 | BeiGene Ltd. | BGNE | Dugan Margaret Director | 33,735 | $0 | 79,690 (Direct) | View |
| 2025-05-21 Option Award | 2025-05-22 7:42 pm | N/A 2035-05-20 | BeiGene Ltd. | BGNE | Sanders Corazon (Corsee) D. Director | 33,735 | $0 | 79,976 (Direct) | View |
| 2025-05-21 Option Award | 2025-05-22 7:41 pm | N/A 2035-05-20 | BeiGene Ltd. | BGNE | HOOPER ANTHONY C Director | 33,735 | $0 | 87,490 (Direct) | View |
| 2025-05-21 Option Award | 2025-05-22 4:10 pm | N/A 2035-05-20 | BeiGene Ltd. | ONC | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 112,970 | $0 | 9,058,960 (Indirect) | View |
| 2025-05-13 Exercise | 2025-05-15 5:37 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 41,760 | $6.5 | 10,603,265 (Direct) | View |
| 2025-05-13 Exercise | 2025-05-15 5:37 pm | N/A 2025-07-19 | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 542,880 | $0 | 10,603,265 (Direct) | View |
| 2025-05-09 Exercise | 2025-05-13 5:24 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 4,055,415 | $0.5 | 54,218,760 (Direct) | View |
| 2025-05-09 Tax Withholding | 2025-05-13 5:24 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 1,990,603 | $17.85 | 54,218,760 (Direct) | View |
| 2025-05-09 Exercise | 2025-05-13 5:24 pm | N/A 2025-07-19 | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 4,055,415 | $0 | 54,218,760 (Direct) | View |
| 2025-04-14 Exercise | 2025-04-16 5:12 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 41,760 | $6.5 | 11,146,145 (Direct) | View |
| 2025-04-14 Exercise | 2025-04-16 5:12 pm | N/A 2025-07-19 | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 542,880 | $0 | 11,146,145 (Direct) | View |
| 2025-04-01 Exercise | 2025-04-03 5:04 pm | N/A N/A | BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China | 35,444 | $174.43 | 1,488,482 (Direct) | View |
| 2025-04-01 Exercise | 2025-04-03 5:04 pm | N/A N/A | BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China | 16,477 | $119.96 | 1,488,482 (Direct) | View |
| 2025-04-01 Exercise | 2025-04-03 5:04 pm | N/A 2029-06-04 | BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China | 674,973 | $0 | 1,488,482 (Direct) | View |
| 2025-03-18 Exercise | 2025-03-20 4:53 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 41,760 | $6.5 | 11,689,025 (Direct) | View |
| 2025-03-18 Exercise | 2025-03-20 4:53 pm | N/A 2025-07-19 | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 542,880 | $0 | 11,689,025 (Direct) | View |
| 2025-03-11 Gift | 2025-03-13 4:43 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 158,717 | $0 | 10,060,378 (Direct) | View |
| 2025-03-10 Exercise | 2025-03-12 5:02 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 497,822 | $0.5 | 50,110,738 (Direct) | View |
| 2025-03-10 Exercise | 2025-03-12 5:02 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 41,210 | $6.5 | 50,110,738 (Direct) | View |
| 2025-03-10 Exercise | 2025-03-12 5:02 pm | N/A 2025-07-19 | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 1,033,552 | $0 | 50,110,738 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-07 8:17 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 708,747 | $0.5 | 51,144,290 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-07 8:17 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 58,590 | $6.5 | 51,144,290 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-07 8:17 pm | N/A 2025-07-19 | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 1,470,417 | $0 | 51,144,290 (Direct) | View |
| 2025-03-06 Exercise | 2025-03-07 7:26 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 486,161 | $0.5 | 52,614,707 (Direct) | View |
| 2025-03-06 Exercise | 2025-03-07 7:26 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 40,109 | $6.5 | 52,614,707 (Direct) | View |
| 2025-03-06 Exercise | 2025-03-07 7:26 pm | N/A 2025-07-19 | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 1,007,578 | $0 | 52,614,707 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 7:26 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 201,084 | $0 | 52,614,707 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 7:24 pm | N/A N/A | BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China | 7,048 | $169.65 | 230,568 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 7:24 pm | N/A N/A | BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China | 44,873 | $119.96 | 230,568 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 7:24 pm | N/A 2028-04-29 | BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China | 674,973 | $0 | 230,568 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 7:24 pm | N/A N/A | BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China | 103,883 | $0 | 230,568 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 7:22 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D | 69,251 | $0 | 1,722,136 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 7:20 pm | N/A N/A | BeiGene Ltd. | BGNE | Lee Chan Henry SVP, General Counsel | 40,209 | $0 | 246,142 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 7:19 pm | N/A N/A | BeiGene Ltd. | BGNE | Rosenberg Aaron Chief Financial Officer | 48,581 | $0 | 167,128 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-05 4:59 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 1,220,531 | $0.5 | 53,627,732 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-05 4:59 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 101,000 | $6.5 | 53,627,732 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-05 4:59 pm | N/A 2025-07-19 | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 2,533,531 | $0 | 53,627,732 (Direct) | View |